title: Bcl-2 expression identifies patients with advanced bladder cancer treated by radiotherapy who benefit from neoadjuvant chemotherapy.
authors.forename: B
authors.initials: B
authors.lastname: Duggan
authors.forename: J
authors.initials: J
authors.lastname: Kelly
authors.forename: P F
authors.initials: PF
authors.lastname: Keane
authors.forename: K
authors.initials: K
authors.lastname: Williamson
authors.forename: S R
authors.initials: SR
authors.lastname: Johnston
mesh_terms: D017024:Chemotherapy, Adjuvant; D006801:Humans; D009363:Neoplasm Proteins / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism*; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy / Q000378:metabolism / Q000532:radiotherapy*
chemical_list: D009363:Neoplasm Proteins; D019253:Proto-Oncogene Proteins c-bcl-2